Dual Fucoidan Composition for AMD Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments and prevention methods for age-related macular degeneration (AMD) are inadequate, as they fail to effectively slow down or treat the progression of the disease.
Innovation Solution
A composition comprising a first fucoidan with antioxidant properties from Saccharina latissima and a second fucoidan with VEGF-inhibiting properties from Laminaria hyperborea, combined with a micronutrient blend of vitamin C, vitamin E, zinc, copper, lutein, and zeaxanthin, formulated as a food supplement or dosage form for oral administration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments and prevention methods are used for AMD, then the disease progression is not effectively slowed down, but this leaves no satisfactory treatment options available
Solution Approach 1:
The invention combines two different fucoidans from distinct brown algae species into a single composition, creating a composite therapeutic agent that delivers multiple mechanisms of action (antioxidant protection and anti-angiogenic effects) simultaneously, thereby improving treatment reliability while providing a versatile solution for AMD management
2Device complexity
If a single fucoidan is used, then the composition is simpler, but it cannot provide both antioxidant protection and VEGF inhibition simultaneously
Solution Approach 1:
The invention merges two distinct fucoidan components with different functional properties into a single integrated composition, enabling the formulation to simultaneously provide antioxidant protection against oxidative stress and VEGF inhibition to suppress abnormal angiogenesis, thus achieving multi-functionality while maintaining compositional integrity
3Device complexity
If fucoidan from one brown algae species is used, then the source is simpler, but it cannot address both oxidative stress and angiogenesis pathways in AMD
Solution Approach 1:
The invention creates a composite formulation by combining fucoidans from two different brown algae species, each contributing distinct therapeutic properties: one species provides potent antioxidant activity to counteract oxidative stress, while the other provides VEGF-inhibiting properties to suppress pathological angiogenesis, thereby addressing multiple harmful factors in AMD
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces oxidative stress and suppresses angiogenesis, thereby slowing down the progression of AMD and reducing the likelihood of vision loss, making it a promising treatment and prevention option for the disease.
Implementation Method 1
The first fucoidan exhibits antioxidant properties
Implementation Method 2
The second fucoidan exhibits VEGF-inhibiting properties
Data Source
AI summary
Composition comprising a first component, comprising a first fucoidan, and a second component, comprising a second fucoidan, wherein the first component differs from the second component.